Flowtuss
- Generic Name: hydrocodone bitartrate and guaifenesin
- Brand Name: Flowtuss
Flowtuss (hydrocodone bitartrate and guaifenesin) side effects drug center
Flowtuss Side Effects Center
Flowtuss (hydrocodone bitartrate and guaifenesin) oral solution is a combination an opioid antitussive and an expectorant indicated for the symptomatic relief of cough and to loosen mucus associated with the common cold. Common side effects of Flowtuss include:
- dizziness,
- headache,
- drowsiness,
- sleepiness,
- nausea,
- decreased blood pressure, and
- hot flashes.
The recommended dose of Flowtuss for adults and adolescents 18 years of age and older is 10 mL every 4 to 6 hours, not to exceed 6 doses (60 mL) in 24 hours. Flowtuss may interact with other opioids, antihistamines, antipsychotics, anti-anxiety agents, other CNS depressants (including alcohol), MAO inhibitors, tricyclic antidepressants, or anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Flowtuss should be used only if prescribed. Hydrocodone passes into breast milk. It is unknown if guaifenesin passes into breast milk. Because of the potential for serious reactions in nursing infants, consult your doctor before breastfeeding. Hydrocodone can produce drug dependence. Withdrawal symptoms may occur if you suddenly stop taking Flowtuss.
Our Flowtuss (hydrocodone bitartrate and guaifenesin) oral solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Flowtuss Professional Information
SIDE EFFECTS
Use of hydrocodone bitartrate is associated with the following:
- Respiratory depression [see WARNINGS AND PRECAUTIONS and OVERDOSAGE]
- Drug dependence [see WARNINGS AND PRECAUTIONS and Drug Abuse and Dependence]
- Increased intracranial pressure [see WARNINGS AND PRECAUTIONS]
- Decreased mental alertness with impaired mental and/or physical abilities [see WARNINGS AND PRECAUTIONS]
- Paralytic ileus [see WARNINGS AND PRECAUTIONS]
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
The most common adverse reactions experienced by subjects taking a single dose of FLOWTUSS in the clinical setting include the following: Central Nervous System: headache, dizziness, sedation (somnolence); Gastrointestinal System: nausea, diarrhea; Cardiovascular System: decreased blood pressure; Vascular System: hot flush.
Read the entire FDA prescribing information for Flowtuss (hydrocodone bitartrate and guaifenesin)
&Copy; Flowtuss Patient Information is supplied by Cerner Multum, Inc. and Flowtuss Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.